about
Oncolytic viruses as therapeutic cancer vaccinesGuidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)Trial WatchImmune checkpoint inhibitors: the new frontier in non-small-cell lung cancer treatmentAggressiveness Niche: Can It Be the Foster Ground for Cancer Metastasis Precursors?Oncolytic viruses as immunotherapy: progress and remaining challengesImmunological Evasion in GlioblastomaNeoadjuvant nab-paclitaxel in the treatment of breast cancerCancer immunotherapy: the beginning of the end of cancer?Big Data Offers Novel Insights for Oncolytic Virus ImmunotherapyExploiting the Immunogenic Potential of Cancer Cells for Improved Dendritic Cell VaccinesExercise in Regulation of Inflammation-Immune Axis Function in Cancer Initiation and ProgressionAutophagy in colorectal cancer: An important switch from physiology to pathologyNecroptotic Cell Death Signaling and Execution Pathway: Lessons from Knockout MiceConcepts and mechanisms underlying chemotherapy induced immunogenic cell death: impact on clinical studies and considerations for combined therapiesNanoparticle Drug Delivery Systems Designed to Improve Cancer Vaccines and ImmunotherapyThe potential of radiotherapy to enhance the efficacy of renal cell carcinoma therapyTrial Watch: Adoptive cell transfer for oncological indicationsPrognostic and Predictive Value of DAMPs and DAMP-Associated Processes in CancerRelevance of tumor-infiltrating lymphocytes in breast cancerNext-generation sequencing: hype and hope for development of personalized radiation therapy?Extracorporeal Photopheresis: Tolerogenic or Immunogenic Cell Death? Beyond Current DogmaThe Tumor Macroenvironment: Cancer-Promoting Networks Beyond Tumor BedsMyeloid Cells as Targets for Therapy in Solid TumorsApoptotic cell clearance: basic biology and therapeutic potential.Therapeutic vaccines as a promising treatment modality against prostate cancer: rationale and recent advancesAcquired and intrinsic resistance in cancer immunotherapyChloroquine and hydroxychloroquine for cancer therapyDendritic Cell Therapy in an Allogeneic-Hematopoietic Cell Transplantation Setting: An Effective Strategy toward Better Disease Control?Combination regimens of radiation therapy and therapeutic cancer vaccines: mechanisms and opportunitiesDamage signals in the insect immune responseHDAC inhibitors and immunotherapy; a double edged sword?Systems biology of cisplatin resistance: past, present and futureCancer immunotherapy via combining oncolytic virotherapy with chemotherapy: recent advancesImmune cell promotion of metastasisTrial Watch: Tumor-targeting monoclonal antibodies in cancer therapyTrial Watch: Immunomodulatory monoclonal antibodies for oncological indicationsAutophagy in malignant transformation and cancer progressionTrial Watch: Immunogenic cell death inducers for anticancer chemotherapyDendritic cell-based vaccination in cancer: therapeutic implications emerging from murine models
P2860
Q21245758-24EA503D-46C5-4B21-8AE1-8978BC292E1EQ22676705-09B5ED2C-809C-4671-9D25-AB14B4821DF3Q24618653-4B67F0B6-6895-43DC-95E4-95798E38DE17Q26738359-B3AC5525-3699-4750-A0B0-8C3F952F24A0Q26738966-94BF8BBB-5948-4E5E-BC50-2BC54590514DQ26745942-FD9D30F3-1031-4B61-8403-CBEE3732DC22Q26746612-F0771968-9DED-4850-8669-E05E94025964Q26748822-4FACC75C-7ED3-41C4-9ABB-7BE2299640A7Q26752277-8A10E861-72F1-48AE-B1FE-E2CACADE6F21Q26767209-63483AD5-0C48-4A3B-B0D9-6B69C9A0DC8EQ26772715-D0AE5F84-D4F2-497F-A1A2-CE59E56B63D5Q26775189-BED595D3-350B-42B1-B379-D25C55332D6FQ26776207-F6DACC6B-E1AA-489B-B58F-516E6A4D0BB3Q26778547-70A01B8C-53C7-45CD-9777-61ED585D3401Q26781215-1EB67816-02D7-4F3A-B54D-78B85DDACC51Q26782566-F565778C-9641-44F3-ABEF-E2C6DED8238AQ26783291-14B6B186-53AA-441B-B5B1-5B7D7253FFCDQ26785545-3C7E75CB-5BCE-495B-B826-65E285D19203Q26795466-C01257E0-7C8A-4A91-A64C-78F9E6FD82DDQ26795598-F3DBF475-1A41-47FA-86B7-522673DF5B99Q26796485-148C3A2B-EF0C-4522-AAC0-AAB4D5315755Q26798468-882E5B96-3D66-44D9-B949-92E495141324Q26799120-9587FFB6-0324-4FED-BCE5-DCDCD574337EQ26801832-ED7D13FA-B6C2-448A-8CCC-BD3F63C55744Q26825935-B039C55C-5A93-4B94-9AEE-636DF871CE94Q26827475-729FE875-B9AA-4375-A90C-25551044D206Q26827701-45A39FB8-1EF8-454F-AE21-6515709FB810Q26827797-E144AA2B-81EC-4EFA-B698-0EAE158EA7B3Q26830857-01124AD9-9295-4010-931A-813A3B98FB0AQ26851710-E0C77179-ED8E-4EC1-9A3E-9F67D54BF837Q26852546-63BAF224-A6E8-457A-8785-8F866393D87EQ26853102-EB301B1F-97A6-438C-AEA3-D0491C6C2A4DQ26863585-179BA4E8-6B19-4A5E-81B7-6A00067BF04DQ26863779-0200CB29-1458-4B09-A5DC-40F97FADAD77Q26991724-5A14F753-B7C7-4778-A6FD-635EBFF0E238Q26993238-B698497D-56AC-4D5E-8945-57913E3CDFDEQ26996518-FCB859CC-5C1A-40DF-8B31-138F4DC95004Q27000191-1316E47F-0819-42CE-9157-CD4B5C289496Q27004011-EB54A246-BAE9-44A1-9A79-F54FEC7C7AF7Q27012618-E384CF86-0258-4783-8C01-1F9FD06C7668
P2860
description
2013 nî lūn-bûn
@nan
2013 թուականին հրատարակուած գիտական յօդուած
@hyw
2013 թվականին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Immunogenic cell death in cancer therapy
@ast
Immunogenic cell death in cancer therapy
@en
type
label
Immunogenic cell death in cancer therapy
@ast
Immunogenic cell death in cancer therapy
@en
prefLabel
Immunogenic cell death in cancer therapy
@ast
Immunogenic cell death in cancer therapy
@en
P3181
P1476
Immunogenic cell death in cancer therapy
@en
P2093
P3181
P356
10.1146/ANNUREV-IMMUNOL-032712-100008
P407
P577
2013-01-01T00:00:00Z